Good MorningEquity markets moved lower on Friday to end an uncertain week on a down note. The market is wrestling with the true meaning of the latest inflation data, and the early analysis is not good. The pace of inflation is stabilizing at current levels if not accelerating, which means the FOMC has yet to accomplish its goal. In this light, it may not be if the FOMC causes a recession but when because it may have to in the fight against inflation.
This week will be another tough one for the market. The following PCE Price index report is due out on Friday and it may echo the news in the CPI data. In this scenario, the odds of another 50 basis point interest rate hike will rise and there is still another month of data to go before the next Fed meeting. The takeaway here is that inflation is still a problem, the FOMC is still raising interest rates and the outlook for S&P 500 earnings is still in decline. Not much of a catalyst for the market to rally on.
Featured: Less than Five Bucks... (PTR) 
|
Markets | | | Wall Street closed another bumpy week with a mixed performance on Friday amid worries that inflation is not cooling as quickly or as smoothly as hoped.
The S&P fell 0.3% after paring a bigger loss from the morning. The Dow Jones Industrial Average rose 129 points, or 0.4%, after ... Read the Full Story |
|
From Our PartnersWhenever the military develops a breakthrough technology, timely investors could see groundbreaking returns.
General Dynamics returned 8,990%...Boeing soared 4,238%...L3Harris shot up 1,628%... | | Here's the next stock we think soars >>> |
|
Stocks | | |
Michael Burry, made famous by the 2015 movie "The Big Short" is a widely known investor whose main focus is - according to a quote by the book and movie - "... find value wherever it can be found."
Well, looks like our Burry has found value in China of all places despite current negative sentimen... Read the Full Story |
|
Markets | | |
Deere & Co. (NYSE: DE) stock is up approximately 4% in early trading after the company’s fourth-quarter earnings report. The heavy equipment manufacturer beat on both the top and bottom lines. The report highlights Deere’s ability to pass along at least some of its higher prices to... Read the Full Story |
|
|
Markets | | |
DraftKings (NASDAQ: DKNG) Q4 report was everything the market could have hoped for and more. Adding new jurisdictions, deepening penetration and increasing monetization have given the company leverage and shortened the time until profitability. The news has the stock up more than 9.0% in premarket... Read the Full Story |
|
Markets | | | Shares were mostly higher in Europe and Asia on Monday after Wall Street closed out another bumpy week marked by uneasiness over the outlook for inflation and interest rates.
Germany's DAX gained 0.1% in early trading to 15,494.14 and the CAC 40 in Paris also was 0.1% higher, at 7,35... Read the Full Story |
|
|
Markets | | | Shares were mostly higher in Asia on Monday after Wall Street closed out another bumpy week marked by uneasiness over the outlook for inflation and interest rates.
U.S. futures edged lower, while oil prices advanced. U.S. markets will be closed for a holiday Monday.
C... Read the Full Story |
|
Markets | | |
It took a while, but it’s looking like Tesla Inc’s (NASDAQ: TSLA) recent price cuts from last month are paying off, and the stock is loving it. Shares of the electric vehicle (EV) king are up 100% from where they started the year, and seemingly well on their way to undoing last year&rs... Read the Full Story |
|
Politics | | | No one in Godgift Inemesit’s family of eight is sure when they will eat each day — except for her three kids, two of whom have malaria. She can't pay for the drugs they need or feed the rest of her family regularly.
Like most Nigerians, the family's savings are trapped in the bank. A... Read the Full Story |
|
Markets | | |
A new study published in Science Translational Medicine could introduce a profitable opportunity for makers of seizure drug medications. The discovery has immense medical implications, of course, but it could lead to a windfall for investors, particularly those holding Abbott Laboratories (NYSE: A... Read the Full Story |
|
Tech | | | A Tesla driver was killed and a passenger was critically injured Saturday when the car plowed into a fire truck that was parked on a Northern California freeway to shield a crew clearing another accident, fire officials said.
Four firefighters who were in the truck when it was struck ... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. | | View Today's Stock Pick |
|
